Anti-IL1B/ IL-1/ IL1-BETA functional antibody
Anti-IL1B/ IL-1/ IL1-BETA functional antibody for cell culture, ELISA & in-vivo assay
Go to IL1B/IL1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T42000-Ab-1/ GM-Tg-hg-T42000-Ab-2 | Anti-Human IL1B monoclonal antibody | Human |
GM-Tg-rg-T42000-Ab-1/ GM-Tg-rg-T42000-Ab-2 | Anti-Rat IL1B monoclonal antibody | Rat |
GM-Tg-mg-T42000-Ab-1/ GM-Tg-mg-T42000-Ab-2 | Anti-Mouse IL1B monoclonal antibody | Mouse |
GM-Tg-cynog-T42000-Ab-1/ GM-Tg-cynog-T42000-Ab-2 | Anti-Cynomolgus/ Rhesus macaque IL1B monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T42000-Ab-1/ GM-Tg-felg-T42000-Ab-2 | Anti-Feline IL1B monoclonal antibody | Feline |
GM-Tg-cang-T42000-Ab-1/ GM-Tg-cang-T42000-Ab-2 | Anti-Canine IL1B monoclonal antibody | Canine |
GM-Tg-bovg-T42000-Ab-1/ GM-Tg-bovg-T42000-Ab-2 | Anti-Bovine IL1B monoclonal antibody | Bovine |
GM-Tg-equg-T42000-Ab-1/ GM-Tg-equg-T42000-Ab-2 | Anti-Equine IL1B monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T42000-Ab-1/ GM-Tg-hg-T42000-Ab-2; GM-Tg-rg-T42000-Ab-1/ GM-Tg-rg-T42000-Ab-2; GM-Tg-mg-T42000-Ab-1/ GM-Tg-mg-T42000-Ab-2; GM-Tg-cynog-T42000-Ab-1/ GM-Tg-cynog-T42000-Ab-2; GM-Tg-felg-T42000-Ab-1/ GM-Tg-felg-T42000-Ab-2; GM-Tg-cang-T42000-Ab-1/ GM-Tg-cang-T42000-Ab-2; GM-Tg-bovg-T42000-Ab-1/ GM-Tg-bovg-T42000-Ab-2; GM-Tg-equg-T42000-Ab-1/ GM-Tg-equg-T42000-Ab-2 |
Products Name | Anti-IL1B monoclonal antibody |
Format | mab |
Target Name | IL1B |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-IL1B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
Target ID | GM-T42000 |
Target Name | IL1B |
Gene ID | 3553,16176,24494,704701,403974,768274,281251 |
Gene Symbol and Synonyms | IL-1,Il-1b,IL-1beta,IL-1F2,IL1-BETA,IL1B,IL1beta,IL1F2 |
Uniprot Accession | P01584,Q63264,P48090,Q28292,P41687,P09428 |
Uniprot Entry Name | IL1B_HUMAN,IL1B_MACMU,IL1B_RAT,IL1B_FELCA,IL1B_CANLF,IL1B_BOVIN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target |
Disease | Breast Cancer, prostate cancer |
Gene Ensembl | ENSG00000125538 |
Target Classification | Checkpoint-Immuno Oncology |
The target: IL1B, gene name: IL1B, also named as IL-1, IL1-BETA, IL1F2. The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. The induction of cyclooxygenase-2 (PTGS2/COX2) by this cytokine in the central nervous system (CNS) is found to contribute to inflammatory pain hypersensitivity. Similarly, IL-1B has been implicated in human osteoarthritis pathogenesis. Patients with severe Coronavirus Disease 2019 (COVID-19) present elevated levels of pro-inflammatory cytokines such as IL-1B in bronchial alveolar lavage fluid samples. The lung damage induced by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to a large extent, a result of the inflammatory response promoted by cytokines such as IL-1B. This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. [provided by RefSeq, Jul 2020].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.